Triangle Securities Wealth Management Increases Position in Danaher Corporation $DHR

Triangle Securities Wealth Management raised its holdings in shares of Danaher Corporation (NYSE:DHR) by 17.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,613 shares of the conglomerate’s stock after buying an additional 985 shares during the period. Triangle Securities Wealth Management’s holdings in Danaher were worth $1,306,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in DHR. GHP Investment Advisors Inc. boosted its position in Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after buying an additional 99 shares during the period. Heck Capital Advisors LLC purchased a new stake in Danaher during the fourth quarter valued at about $27,000. Sierra Ocean LLC boosted its position in Danaher by 116.9% during the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after buying an additional 76 shares during the period. Smallwood Wealth Investment Management LLC purchased a new stake in Danaher during the first quarter valued at about $31,000. Finally, Dunhill Financial LLC boosted its position in Danaher by 68.4% during the first quarter. Dunhill Financial LLC now owns 165 shares of the conglomerate’s stock valued at $34,000 after buying an additional 67 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 11.10% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several analysts have issued reports on the stock. Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research report on Tuesday, September 2nd. Evercore ISI dropped their target price on shares of Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a report on Tuesday, July 8th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 target price for the company in a report on Friday, July 11th. Robert W. Baird increased their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a report on Friday, July 18th. Finally, UBS Group dropped their target price on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Seventeen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $246.35.

Danaher Price Performance

DHR stock opened at $195.26 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $279.90. The company has a market cap of $139.82 billion, a P/E ratio of 41.55, a PEG ratio of 2.69 and a beta of 0.75. The firm has a 50-day moving average of $200.40 and a 200 day moving average of $198.47. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. During the same period in the prior year, the firm earned $1.72 earnings per share. Danaher’s revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.